nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4A—chronic obstructive pulmonary disease	0.372	1	CbGaD
Flavoxate—PDE4C—Roflumilast—chronic obstructive pulmonary disease	0.143	0.259	CbGbCtD
Flavoxate—PDE4D—Roflumilast—chronic obstructive pulmonary disease	0.133	0.24	CbGbCtD
Flavoxate—PDE4A—Roflumilast—chronic obstructive pulmonary disease	0.0983	0.178	CbGbCtD
Flavoxate—PDE4B—Roflumilast—chronic obstructive pulmonary disease	0.0937	0.169	CbGbCtD
Flavoxate—PDE4A—Aminophylline—chronic obstructive pulmonary disease	0.0539	0.0974	CbGbCtD
Flavoxate—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0164	0.0297	CbGbCtD
Flavoxate—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0151	0.0273	CbGbCtD
Flavoxate—PDE8B—leg—chronic obstructive pulmonary disease	0.00717	0.356	CbGeAlD
Flavoxate—PDE8B—bronchus—chronic obstructive pulmonary disease	0.00147	0.0729	CbGeAlD
Flavoxate—PDE8A—bronchus—chronic obstructive pulmonary disease	0.00132	0.0656	CbGeAlD
Flavoxate—PDE8A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00129	0.0641	CbGeAlD
Flavoxate—PDE7B—lung—chronic obstructive pulmonary disease	0.00119	0.0591	CbGeAlD
Flavoxate—PDE8A—trachea—chronic obstructive pulmonary disease	0.00118	0.0589	CbGeAlD
Flavoxate—PDE8B—lung—chronic obstructive pulmonary disease	0.000946	0.047	CbGeAlD
Flavoxate—PDE8A—lung—chronic obstructive pulmonary disease	0.000851	0.0423	CbGeAlD
Flavoxate—PDE4D—lung—chronic obstructive pulmonary disease	0.000771	0.0383	CbGeAlD
Flavoxate—PDE4B—respiratory system—chronic obstructive pulmonary disease	0.000767	0.0381	CbGeAlD
Flavoxate—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000731	0.0275	CcSEcCtD
Flavoxate—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000723	0.0272	CcSEcCtD
Flavoxate—PDE4A—lung—chronic obstructive pulmonary disease	0.000683	0.0339	CbGeAlD
Flavoxate—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000669	0.0252	CcSEcCtD
Flavoxate—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000658	0.0247	CcSEcCtD
Flavoxate—PDE4B—bronchus—chronic obstructive pulmonary disease	0.000631	0.0313	CbGeAlD
Flavoxate—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00059	0.0222	CcSEcCtD
Flavoxate—PDE4B—trachea—chronic obstructive pulmonary disease	0.000566	0.0281	CbGeAlD
Flavoxate—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000526	0.0198	CcSEcCtD
Flavoxate—CHRM1—trachea—chronic obstructive pulmonary disease	0.000512	0.0254	CbGeAlD
Flavoxate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000501	0.0188	CcSEcCtD
Flavoxate—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000487	0.0183	CcSEcCtD
Flavoxate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000483	0.0182	CcSEcCtD
Flavoxate—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000482	0.0181	CcSEcCtD
Flavoxate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000474	0.0178	CcSEcCtD
Flavoxate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.0172	CcSEcCtD
Flavoxate—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.0166	CcSEcCtD
Flavoxate—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000439	0.0165	CcSEcCtD
Flavoxate—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.0156	CcSEcCtD
Flavoxate—PDE4B—lung—chronic obstructive pulmonary disease	0.000407	0.0202	CbGeAlD
Flavoxate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000395	0.0149	CcSEcCtD
Flavoxate—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.0147	CcSEcCtD
Flavoxate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000386	0.0145	CcSEcCtD
Flavoxate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000381	0.0143	CcSEcCtD
Flavoxate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000373	0.014	CcSEcCtD
Flavoxate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.014	CcSEcCtD
Flavoxate—Tension—Formoterol—chronic obstructive pulmonary disease	0.000371	0.0139	CcSEcCtD
Flavoxate—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.0139	CcSEcCtD
Flavoxate—CHRM1—lung—chronic obstructive pulmonary disease	0.000368	0.0183	CbGeAlD
Flavoxate—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.0138	CcSEcCtD
Flavoxate—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000367	0.0138	CcSEcCtD
Flavoxate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000361	0.0136	CcSEcCtD
Flavoxate—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.0132	CcSEcCtD
Flavoxate—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.013	CcSEcCtD
Flavoxate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000334	0.0126	CcSEcCtD
Flavoxate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.0126	CcSEcCtD
Flavoxate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000327	0.0123	CcSEcCtD
Flavoxate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000322	0.0121	CcSEcCtD
Flavoxate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.0121	CcSEcCtD
Flavoxate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.0119	CcSEcCtD
Flavoxate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.0118	CcSEcCtD
Flavoxate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000315	0.0118	CcSEcCtD
Flavoxate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000304	0.0114	CcSEcCtD
Flavoxate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.0113	CcSEcCtD
Flavoxate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000301	0.0113	CcSEcCtD
Flavoxate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.0113	CcSEcCtD
Flavoxate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.0003	0.0113	CcSEcCtD
Flavoxate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.0112	CcSEcCtD
Flavoxate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000293	0.011	CcSEcCtD
Flavoxate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.0107	CcSEcCtD
Flavoxate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.0106	CcSEcCtD
Flavoxate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.0103	CcSEcCtD
Flavoxate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000274	0.0103	CcSEcCtD
Flavoxate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000269	0.0101	CcSEcCtD
Flavoxate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00974	CcSEcCtD
Flavoxate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00969	CcSEcCtD
Flavoxate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00956	CcSEcCtD
Flavoxate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00956	CcSEcCtD
Flavoxate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00955	CcSEcCtD
Flavoxate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00921	CcSEcCtD
Flavoxate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00921	CcSEcCtD
Flavoxate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00914	CcSEcCtD
Flavoxate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00905	CcSEcCtD
Flavoxate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00903	CcSEcCtD
Flavoxate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00903	CcSEcCtD
Flavoxate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.009	CcSEcCtD
Flavoxate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.0087	CcSEcCtD
Flavoxate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000227	0.00854	CcSEcCtD
Flavoxate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00738	CcSEcCtD
Flavoxate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00738	CcSEcCtD
Flavoxate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00727	CcSEcCtD
Flavoxate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00727	CcSEcCtD
Flavoxate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00725	CcSEcCtD
Flavoxate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00722	CcSEcCtD
Flavoxate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00712	CcSEcCtD
Flavoxate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00696	CcSEcCtD
Flavoxate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00692	CcSEcCtD
Flavoxate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00689	CcSEcCtD
Flavoxate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00689	CcSEcCtD
Flavoxate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00686	CcSEcCtD
Flavoxate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00675	CcSEcCtD
Flavoxate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00651	CcSEcCtD
Flavoxate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00613	CcSEcCtD
Flavoxate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00527	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00518	CcSEcCtD
Flavoxate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00503	CcSEcCtD
Flavoxate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00499	CcSEcCtD
Flavoxate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00446	CcSEcCtD
Flavoxate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00443	CcSEcCtD
Flavoxate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00394	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00376	CcSEcCtD
Flavoxate—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.92e-05	0.00373	CcSEcCtD
Flavoxate—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.64e-05	0.00363	CcSEcCtD
Flavoxate—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.0029	CcSEcCtD
Flavoxate—Headache—Prednisone—chronic obstructive pulmonary disease	7.6e-05	0.00286	CcSEcCtD
Flavoxate—Nausea—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.00271	CcSEcCtD
Flavoxate—PDE4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.88e-05	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.88e-05	0.00102	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.85e-05	0.00101	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.84e-05	0.00101	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.84e-05	0.001	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	2.83e-05	0.001	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.82e-05	0.000998	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.77e-05	0.000982	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.77e-05	0.000979	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.77e-05	0.000979	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.76e-05	0.000975	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.72e-05	0.000963	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.72e-05	0.000961	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.71e-05	0.000958	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.68e-05	0.000947	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.67e-05	0.000944	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.000939	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.64e-05	0.000935	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.63e-05	0.000929	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.62e-05	0.000927	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.61e-05	0.000923	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.59e-05	0.000916	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.58e-05	0.000913	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.58e-05	0.000912	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.56e-05	0.000907	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.51e-05	0.000889	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.5e-05	0.000883	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.48e-05	0.000879	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.47e-05	0.000873	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.47e-05	0.000873	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.46e-05	0.000872	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.44e-05	0.000864	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.4e-05	0.000848	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.38e-05	0.000844	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	2.38e-05	0.000844	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.000838	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.34e-05	0.000829	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.3e-05	0.000813	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.29e-05	0.000811	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000811	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.28e-05	0.000805	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.28e-05	0.000805	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.27e-05	0.000802	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.26e-05	0.000801	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.25e-05	0.000798	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.24e-05	0.000792	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.23e-05	0.00079	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.23e-05	0.000788	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.2e-05	0.00078	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.17e-05	0.000768	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.17e-05	0.000768	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.09e-05	0.000738	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.09e-05	0.000738	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.07e-05	0.000734	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.07e-05	0.000734	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.06e-05	0.000728	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.03e-05	0.000718	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.01e-05	0.000712	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2e-05	0.000706	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.99e-05	0.000703	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.99e-05	0.000703	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.98e-05	0.000702	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.97e-05	0.000697	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.94e-05	0.000686	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.94e-05	0.000685	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.89e-05	0.000667	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.87e-05	0.000663	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.85e-05	0.000655	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.85e-05	0.000655	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.85e-05	0.000654	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.85e-05	0.000653	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000651	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000651	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.84e-05	0.00065	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.84e-05	0.00065	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.83e-05	0.000647	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.8e-05	0.000638	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.000637	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.79e-05	0.000633	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.000625	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.000622	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000619	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000619	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.75e-05	0.000618	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.74e-05	0.000617	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.72e-05	0.00061	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.72e-05	0.000608	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.71e-05	0.000604	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.7e-05	0.000603	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.7e-05	0.000601	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.000595	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.67e-05	0.000591	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.66e-05	0.000589	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.66e-05	0.000589	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.00058	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.61e-05	0.00057	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.61e-05	0.000569	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.6e-05	0.000566	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.58e-05	0.000558	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.56e-05	0.000552	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.53e-05	0.000543	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000539	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.52e-05	0.000539	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.49e-05	0.000529	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.49e-05	0.000529	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.49e-05	0.000529	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.48e-05	0.000525	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000518	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.45e-05	0.000514	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.45e-05	0.000513	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.000502	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.000501	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.41e-05	0.000499	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.4e-05	0.000495	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.000495	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.4e-05	0.000495	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000493	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.38e-05	0.00049	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.38e-05	0.000488	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000485	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.37e-05	0.000485	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.37e-05	0.000485	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.34e-05	0.000476	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.34e-05	0.000476	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.34e-05	0.000474	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.33e-05	0.000471	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.000471	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.32e-05	0.000468	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.3e-05	0.00046	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.000456	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.28e-05	0.000453	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.26e-05	0.000447	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.25e-05	0.000441	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000438	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.24e-05	0.000438	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.24e-05	0.000438	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.23e-05	0.000436	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.23e-05	0.000435	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.000432	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000424	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.17e-05	0.000415	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.000406	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.15e-05	0.000405	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.14e-05	0.000402	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.13e-05	0.000401	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.13e-05	0.0004	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.13e-05	0.000399	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.13e-05	0.000399	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.13e-05	0.000399	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000396	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000394	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.11e-05	0.000394	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.08e-05	0.000382	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000382	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.07e-05	0.00038	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.07e-05	0.000379	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.07e-05	0.000377	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000377	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.03e-05	0.000366	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.03e-05	0.000366	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.02e-05	0.000362	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	0.000361	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.00036	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000358	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-05	0.000356	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.93e-06	0.000351	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.87e-06	0.000349	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.74e-06	0.000345	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.74e-06	0.000345	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.72e-06	0.000344	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.44e-06	0.000334	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.42e-06	0.000333	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.35e-06	0.000331	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.28e-06	0.000328	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.21e-06	0.000326	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.99e-06	0.000318	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.98e-06	0.000318	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.96e-06	0.000317	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.84e-06	0.000313	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.64e-06	0.000306	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.58e-06	0.000304	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.56e-06	0.000303	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.23e-06	0.000291	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.22e-06	0.000291	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.06e-06	0.000285	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.89e-06	0.000279	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.82e-06	0.000277	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.82e-06	0.000277	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.79e-06	0.000276	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.61e-06	0.000269	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.44e-06	0.000263	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.4e-06	0.000262	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.34e-06	0.00026	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.26e-06	0.000257	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.24e-06	0.000256	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.24e-06	0.000256	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.02e-06	0.000248	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.89e-06	0.000244	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.77e-06	0.00024	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.68e-06	0.000237	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.68e-06	0.000237	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.44e-06	0.000228	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.32e-06	0.000224	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.18e-06	0.000219	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.13e-06	0.000217	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.1e-06	0.000216	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.09e-06	0.000216	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.05e-06	0.000214	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.02e-06	0.000213	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.01e-06	0.000213	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.97e-06	0.000211	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.68e-06	0.000201	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.58e-06	0.000197	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.56e-06	0.000197	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.53e-06	0.000196	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.5e-06	0.000195	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.46e-06	0.000193	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.43e-06	0.000192	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.3e-06	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.29e-06	0.000187	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.22e-06	0.000185	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.05e-06	0.000179	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.92e-06	0.000174	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.86e-06	0.000172	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.86e-06	0.000172	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.67e-06	0.000165	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.62e-06	0.000164	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.28e-06	0.000151	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.05e-06	0.000143	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.99e-06	0.000141	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.86e-06	0.000137	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.81e-06	0.000135	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.69e-06	0.00013	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.64e-06	0.000129	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.27e-06	0.000116	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.23e-06	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.11e-06	0.00011	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.07e-06	0.000109	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.96e-06	0.000105	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.92e-06	0.000103	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.66e-06	9.4e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.62e-06	9.28e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.44e-06	8.63e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.41e-06	8.52e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.39e-06	8.46e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.36e-06	8.35e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.01e-06	7.1e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.98e-06	7.01e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.84e-06	6.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.81e-06	6.42e-05	CbGpPWpGaD
